110 related articles for article (PubMed ID: 16906572)
21. Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia.
Bosch F; Muntañola A; Giné E; Carrió A; Villamor N; Moreno C; Crespo M; Montserrat E
Cytometry B Clin Cytom; 2006 Jul; 70(4):214-7. PubMed ID: 16906580
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L
Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928
[TBL] [Abstract][Full Text] [Related]
23. A single tube, four-color flow cytometry assay for evaluation of ZAP-70 and CD38 expression in chronic lymphocytic leukemia.
Hassanein NM; Perkinson KR; Alcancia F; Goodman BK; Weinberg JB; Lagoo AS
Am J Clin Pathol; 2010 May; 133(5):708-17. PubMed ID: 20395517
[TBL] [Abstract][Full Text] [Related]
24. A standardized ZAP-70 assay--lessons learned in the trenches.
Shults KE; Miller DT; Davis BH; Flye L; Hobbs LA; Stelzer GT
Cytometry B Clin Cytom; 2006 Jul; 70(4):276-83. PubMed ID: 16906586
[TBL] [Abstract][Full Text] [Related]
25. A robust ratio metric method for analysis of Zap-70 expression in chronic lymphocytic leukemia (CLL).
Bakke AC; Purtzer Z; Leis J; Huang J
Cytometry B Clin Cytom; 2006 Jul; 70(4):227-34. PubMed ID: 16342060
[TBL] [Abstract][Full Text] [Related]
26. T-cell CD38 expression in B-chronic lymphocytic leukaemia.
Abousamra NK; El-Din MS; Azmy E
Hematol Oncol; 2009 Jun; 27(2):82-9. PubMed ID: 19247976
[TBL] [Abstract][Full Text] [Related]
27. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
[TBL] [Abstract][Full Text] [Related]
28. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Soma LA; Craig FE; Swerdlow SH
Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
[TBL] [Abstract][Full Text] [Related]
29. Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels.
Rivkina A; Vitols G; Murovska M; Lejniece S
Exp Oncol; 2011 Jun; 33(2):99-103. PubMed ID: 21716207
[TBL] [Abstract][Full Text] [Related]
30. Kolmogorov-Smirnov statistical test for analysis of ZAP-70 expression in B-CLL, compared with quantitative PCR and IgV(H) mutation status.
Van Bockstaele F; Janssens A; Piette A; Callewaert F; Pede V; Offner F; Verhasselt B; Philippé J
Cytometry B Clin Cytom; 2006 Jul; 70(4):302-8. PubMed ID: 16906582
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
Hojjat Farsangi M; Jeddi-Tehrani M; Razavi SM; Sharifian RA; Shamsian Khoramabadi A; Rabbani H; Shokri F
Iran J Immunol; 2008 Mar; 5(1):25-35. PubMed ID: 18319522
[TBL] [Abstract][Full Text] [Related]
32. [ZAP-70 expression in 24 patients with B cell chronic lymphocytic leukemia].
Wu YJ; Li JY; Zhu GR; Song JH; Xiao B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):237-40. PubMed ID: 16638188
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
34. ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage.
Scielzo C; Camporeale A; Geuna M; Alessio M; Poggi A; Zocchi MR; Chilosi M; Caligaris-Cappio F; Ghia P
Leukemia; 2006 Apr; 20(4):689-95. PubMed ID: 16482211
[TBL] [Abstract][Full Text] [Related]
35. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M
Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718
[TBL] [Abstract][Full Text] [Related]
36. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
Babusíková O; Zelezníková T; Mlcáková A; Kusenda J; Stevulová L
Neoplasma; 2005; 52(6):502-9. PubMed ID: 16284697
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometry for ZAP-70: New colors for chronic lymphocytic leukemia.
Wiestner A
Cytometry B Clin Cytom; 2006 Jul; 70(4):201-3. PubMed ID: 16906579
[TBL] [Abstract][Full Text] [Related]
38. CD38 as a prognostic factor in B cell chronic lymphocytic leukaemia (B-CLL): comparison of three approaches to analyze its expression.
Boonstra JG; van Lom K; Langerak AW; Graveland WJ; Valk PJ; Kraan J; van 't Veer MB; Gratama JW
Cytometry B Clin Cytom; 2006 May; 70(3):136-41. PubMed ID: 16568475
[TBL] [Abstract][Full Text] [Related]
39. B lymphocytes in humans express ZAP-70 when activated in vivo.
Cutrona G; Colombo M; Matis S; Reverberi D; Dono M; Tarantino V; Chiorazzi N; Ferrarini M
Eur J Immunol; 2006 Mar; 36(3):558-69. PubMed ID: 16482508
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of ZAP-70 and CD 38 in Indian chronic lymphocytic leukemia patients.
Gogia A; Sharma A; Raina V; Kumar L; Gupta R; Kumar R
Indian J Cancer; 2013; 50(4):333-6. PubMed ID: 24369212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
